Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes

Site-specific delivery of chemotherapeutics specifically to neoplastic hepatocytes without affecting normal hepatocytes should be a focus for potential therapeutic management of hepatocellular carcinoma (HCC). The aptamer TLS 9a with phosphorothioate backbone modifications (L5) has not been explored...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Samrat, Dlie, Zewdu Yilma, Chakraborty, Somdyuti, Roy, Somdatta, Mukherjee, Biswajit, Besra, Shila Elizabeth, Dewanjee, Saikat, Mukherjee, Alankar, Ojha, Probir Kumar, Kumar, Vinay, Sen, Ramkrishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063179/
https://www.ncbi.nlm.nih.gov/pubmed/32146417
http://dx.doi.org/10.1016/j.omtn.2020.01.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063179/
https://www.ncbi.nlm.nih.gov/pubmed/32146417
http://dx.doi.org/10.1016/j.omtn.2020.01.034

Ejemplares similares